NCT06494982

Brief Summary

This is a prospective randomized controlled trial designed to compare the effectiveness and safety of two methods of pelvic floor reconstruction in patients with pelvic organ prolapse (POP): sacrospinous hysteropexy (SSHP) with synthetic mesh, vascularized anterior vaginal wall flap, anterior colporrhaphy, and sacrospinous hysteropexy with synthetic mesh. , anterior colporrhaphy, as well as the impact of surgery on quality of life.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 10, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

July 10, 2024

Status Verified

July 1, 2024

Enrollment Period

5 months

First QC Date

March 25, 2024

Last Update Submit

July 2, 2024

Conditions

Keywords

pelvic organ prolapsevaginal repairvaginal meshsacrospinous fixationvaginal flap

Outcome Measures

Primary Outcomes (1)

  • Objective cure rate

    The patient is considered cured if there is no prolapse beyond the hymen and the cervix is above -1 cm according to POP-Q (0-1 stage)

    12 months (1 year)

Secondary Outcomes (4)

  • Satisfaction with the surgery

    Measured postoperatively at intervals of 6, 12 months postoperatively, up to 100 weeks

  • The impact of treatment on sexual function

    Measured postoperatively at intervals of 6, 12 months postoperatively, Measured postoperatively at intervals of 6, 12 months postoperatively, up to 100 weeks

  • The impact of treatment on the quality of life

    Measured postoperatively at intervals of 6, 12 months postoperatively, Measured postoperatively at intervals of 6, 12 months postoperatively, up to 100 weeks

  • Observed complications

    Measured postoperatively at intervals of 6, 12 months postoperatively, Measured postoperatively at intervals of 6, 12 months postoperatively, up to 100 weeks

Study Arms (2)

Sacrospinous hysteropexy with the synthetic mesh, vaginal flap and anterior colporrhaphy

ACTIVE COMPARATOR
Procedure: Sacrospinous hysteropexy with the synthetic mesh, vaginal flap and anterior colporrhaphy

Sacrospinous hysteropexy with the synthetic mesh and anterior colporrhaphy

ACTIVE COMPARATOR
Procedure: Sacrospinous hysteropexy with the synthetic mesh and anterior colporrhaphy

Interventions

Sacrospinous hysteropexy with the synthetic mesh, vaginal flap and anterior colporrhaphy

Sacrospinous hysteropexy with the synthetic mesh, vaginal flap and anterior colporrhaphy

Sacrospinous hysteropexy with the synthetic mesh and anterior colporrhaphy

Sacrospinous hysteropexy with the synthetic mesh and anterior colporrhaphy

Eligibility Criteria

Age45 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The subject is a woman with anterior and apical compartment pelvic organ prolapse
  • The age of a subject is 45-80 years
  • Leading point of prolapse is at the level of the hymen or distal to the hymen (Ba, C\>=1 according to POP-Q classification)
  • The subject gave written consent to participate in the study
  • The subject is able to evaluate the risks of the treatment and make an independent decision on participation in the study
  • The subject is able to fill up validated questionnaires and come to the control visit after the surgery

You may not qualify if:

  • The subject has an active urinary tract infection or skin infection in the region of surgery or acute infectious disease
  • The subject had prior hysterectomy
  • The subject has previously diagnosed or currently active cancer
  • The subject has chronic pelvic pain
  • The subject has cervical elongation
  • The subject has gynecological diseases (recurrent uterine bleeding, endometrial hyperplasia, the presence of atypical cells in cervical smears, adenomyosis, multiple uterine myoma)
  • The subject is planning pregnancy
  • The subject is unable to visit postoperative check-ups
  • Refusal from participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint-Petersburg State University Hospital

Saint Petersburg, 190103, Russia

RECRUITING

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Dmitry Shkarupa, MD, PhD

    Saint Petersburg State University, Russia

    STUDY CHAIR

Central Study Contacts

Denis Suchkov, MD

CONTACT

Rustam Shakhaliev, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD; Director, St. Petersburg State University Hospital

Study Record Dates

First Submitted

March 25, 2024

First Posted

July 10, 2024

Study Start

May 1, 2024

Primary Completion

October 1, 2024

Study Completion

October 1, 2025

Last Updated

July 10, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations